Logo image of AMV

ATLIS MOTOR VEHICLES I- CL A (AMV) Stock Fundamental Analysis

NASDAQ:AMV - Nasdaq - US0495061089 - Common Stock - Currency: USD

0.5041  -0.01 (-1.5%)

After market: 0.5134 +0.01 (+1.84%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to AMV. AMV was compared to 129 industry peers in the Machinery industry. Both the profitability and financial health of AMV have multiple concerns. AMV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AMV has reported negative net income.
In the past 5 years AMV always reported negative net income.
AMV had a negative operating cash flow in each of the past 5 years.
AMV Yearly Net Income VS EBIT VS OCF VS FCFAMV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -20M -40M -60M -80M -100M

1.2 Ratios

AMV has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMV Yearly ROA, ROE, ROICAMV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -10K -20K -30K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMV Yearly Profit, Operating, Gross MarginsAMV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022

More info and screens

0

2. Health

2.1 Basic Checks

AMV has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, AMV has a worse debt to assets ratio.
AMV Yearly Shares OutstandingAMV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 5M 10M
AMV Yearly Total Debt VS Total AssetsAMV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

AMV has an Altman-Z score of -139.33. This is a bad value and indicates that AMV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -139.33, AMV is not doing good in the industry: 93.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -139.33
ROIC/WACCN/A
WACCN/A
AMV Yearly LT Debt VS Equity VS FCFAMV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 10M -10M -20M

2.3 Liquidity

AMV has a Current Ratio of 0.86. This is a bad value and indicates that AMV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AMV (0.86) is worse than 93.98% of its industry peers.
AMV has a Quick Ratio of 0.86. This is a bad value and indicates that AMV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AMV (0.86) is worse than 69.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.86
AMV Yearly Current Assets VS Current LiabilitesAMV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 0 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

AMV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.09%.
EPS 1Y (TTM)6.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

AMV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.83% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y79.52%
EPS Next 2Y37.09%
EPS Next 3Y23.83%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMV Yearly Revenue VS EstimatesAMV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
AMV Yearly EPS VS EstimatesAMV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMV Price Earnings VS Forward Price EarningsAMV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMV Per share dataAMV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -5 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as AMV's earnings are expected to grow with 23.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.09%
EPS Next 3Y23.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATLIS MOTOR VEHICLES I- CL A

NASDAQ:AMV (5/12/2023, 8:17:03 PM)

After market: 0.5134 +0.01 (+1.84%)

0.5041

-0.01 (-1.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-16 2023-03-16/amc
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap33.71M
Analysts80
Price Target2.04 (304.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-86.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.79%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-14.6
EYN/A
EPS(NY)-1.82
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.86
Altman-Z -139.33
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)787.54%
Cap/Depr(5y)572.53%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y79.52%
EPS Next 2Y37.09%
EPS Next 3Y23.83%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.61%
EBIT Next 3Y17.12%
EBIT Next 5YN/A
FCF growth 1Y-107.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.36%
OCF growth 3YN/A
OCF growth 5YN/A